Plavix 75 mg (clopidogrel) is a prescription antiplatelet medicine that prevents platelets from clumping together and forming clots inside arteries. It belongs to the P2Y12 inhibitor class. Depending on the patient's condition, clopidogrel may be used to lower the risk of heart attack or stroke and to prevent clot-related complications from certain coronary conditions.
Plavix contains clopidogrel, which the body converts into an active metabolite that blocks the P2Y12 platelet receptor, reducing platelet activation and aggregation. The conversion relies on the CYP2C19 enzyme pathway. Some people do not convert clopidogrel as efficiently as others, which can affect how well it works.
Plavix 75 mg may be prescribed for: Recent myocardial infarction (heart attack) Recent ischemic stroke Established peripheral arterial disease Acute coronary syndrome, including certain forms of unstable angina and myocardial infarction Reducing the risk of further cardiovascular events in appropriate patients
Clopidogrel blocks the P2Y12 ADP receptor on platelets. That reduces how readily platelets activate and stick together, lowering the chance of arterial clot formation.
For most approved indications, the maintenance dose is 75 mg once daily. In certain acute coronary syndrome situations, treatment starts with a higher loading dose before dropping to 75 mg once daily. The specific regimen depends on the patient's condition and should be set by the prescribing clinician. Take Plavix exactly as prescribed, at roughly the same time each day. Do not stop taking it without speaking to your doctor first. Stopping abruptly, particularly after a coronary stent has been placed, can raise the risk of serious cardiovascular events.
Bleeding is the main risk with Plavix. Patients may bruise more easily or take longer to stop bleeding than usual. Tell your doctor or pharmacist about all prescription medicines, over-the-counter drugs, and supplements you take. Omeprazole and esomeprazole can interact with clopidogrel. NSAIDs can add to bleeding risk when taken alongside it. Clopidogrel is contraindicated in patients with active pathological bleeding. Further precautions apply to people with certain histories of stroke or bleeding disorders. Common Side Effects Side effects may include easy bruising or bleeding, nosebleeds, headache, dizziness, nausea, diarrhea, stomach discomfort, and fatigue. Get medical attention promptly for signs of serious bleeding: black or bloody stools, blood in urine, vomiting blood, or bleeding that will not stop.
Store Plavix per the product label. FDA-listed labeling specifies 15–30°C (59–86°F). Keep in the original container, away from heat and moisture, and out of reach of children.
Reducing the risk of harmful arterial blood clots in people with certain cardiovascular conditions, including recent heart attack, recent stroke, peripheral arterial disease, and acute coronary syndrome.
Clopidogrel.
It is often called one, but Plavix is an antiplatelet medicine, not an anticoagulant. It targets platelet aggregation rather than the clotting cascade.
Not without talking to your doctor first. Stopping clopidogrel early can raise the risk of heart attack or stroke. That risk is especially serious in patients who have had a coronary stent placed.
It can. Reduced platelet aggregation means cuts and injuries may bleed more freely or take longer to clot.
Clopidogrel is sometimes prescribed alongside aspirin as dual antiplatelet therapy, particularly after certain coronary interventions or in acute coronary syndrome. Whether this combination suits a particular patient is a clinical decision.
Yes, and tell any other clinician before procedures or surgery. Do not stop the medication unless instructed by the relevant healthcare professional.
Follow your prescription instructions and ask your pharmacist or doctor what to do. Do not double your next dose unless specifically told to.